Boston, MA, United States of America

Massimo Merighi

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Ginkgo Bioworks, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Massimo Merighi. Retrieved from https://idiyas.com/inventor/massimo-merighi-9325f1pr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Massimo Merighi: Innovator in Cannabinoid Biosynthesis

Introduction

Massimo Merighi is a prominent inventor based in Boston, MA, known for his contributions to the field of cannabinoid biosynthesis. His innovative work focuses on the development of methods for producing cannabinoids and their precursors using recombinant cells and in vitro techniques.

Latest Patents

Merighi holds a patent for the "Biosynthesis of cannabinoids and cannabinoid precursors." This patent highlights the advancements in the biosynthesis process, showcasing the potential for creating cannabinoids in a more efficient and controlled manner.

Career Highlights

Massimo Merighi is currently employed at Ginkgo Bioworks, Inc., a company renowned for its work in synthetic biology. His role at Ginkgo Bioworks allows him to collaborate with other leading scientists and contribute to groundbreaking research in the field.

Collaborations

Some of his notable coworkers include Kim Cecelia Anderson and Elena E Brevnova, who work alongside him in advancing the research and development of cannabinoid biosynthesis.

Conclusion

Massimo Merighi's innovative work in cannabinoid biosynthesis positions him as a key figure in the field, with significant contributions that may impact various applications in medicine and industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…